Free Trial

William Blair Increases Earnings Estimates for agilon health

agilon health logo with Medical background

agilon health, inc. (NYSE:AGL - Free Report) - Analysts at William Blair raised their Q1 2026 EPS estimates for shares of agilon health in a research note issued to investors on Tuesday, May 6th. William Blair analyst R. Daniels now expects that the company will earn $0.09 per share for the quarter, up from their previous forecast of $0.05. The consensus estimate for agilon health's current full-year earnings is ($0.59) per share.

Other equities research analysts also recently issued research reports about the company. JMP Securities reiterated a "market perform" rating on shares of agilon health in a research report on Monday, April 28th. Robert W. Baird reduced their price target on agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Cowen reissued a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Royal Bank of Canada lifted their target price on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Finally, Needham & Company LLC reissued a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $4.90.

Read Our Latest Stock Analysis on AGL

agilon health Stock Performance

Shares of agilon health stock traded down $0.32 on Thursday, reaching $2.65. 3,844,742 shares of the company traded hands, compared to its average volume of 4,895,508. The company has a 50 day moving average of $4.26 and a 200 day moving average of $3.20. agilon health has a 52 week low of $1.50 and a 52 week high of $7.73. The firm has a market capitalization of $1.10 billion, a PE ratio of -2.82 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

agilon health (NYSE:AGL - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same period in the previous year, the company posted ($0.02) EPS. The firm's revenue was down 4.5% compared to the same quarter last year.

Hedge Funds Weigh In On agilon health

Several hedge funds have recently made changes to their positions in the business. Oak Thistle LLC acquired a new stake in agilon health during the 4th quarter valued at $25,000. Ieq Capital LLC acquired a new stake in agilon health during the 4th quarter worth about $26,000. Signaturefd LLC increased its holdings in shares of agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares during the period. Humankind Investments LLC purchased a new stake in shares of agilon health in the fourth quarter worth approximately $30,000. Finally, Raymond James Financial Inc. acquired a new stake in shares of agilon health during the 4th quarter valued at $33,000.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Recommended Stories

Earnings History and Estimates for agilon health (NYSE:AGL)

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines